Microchip Technology (MCHP) Financials

$60.80 +0.23 (+0.38%)

As of 04:00 PM Eastern

Annual Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015
Net Income / (Loss) Attributable to Common Shareholders	1,907	2,238	1,286	349	571	356	255	165	324	369
Consolidated Net Income / (Loss)	1,907	2,238	1,286	349	571	356	255	165	324	365
Net Income / (Loss) Continuing Operations	1,907	2,238	1,286	349	571	356	255	171	324	365
Total Pre-Tax Income	2,366	2,910	1,483	340	150	205	737	90	281	346
Total Operating Income	2,571	3,116	1,850	998	647	714	936	276	352	426
Total Gross Profit	4,996	5,698	4,450	3,379	3,242	2,931	2,421	1,757	1,206	1,230
Total Revenue	7,634	8,439	6,821	5,438	5,274	5,350	3,981	3,408	2,173	2,147
Operating Revenue	7,634	8,439	6,821	5,438	5,274	5,350	3,981	3,408	2,173	2,147
Total Cost of Revenue	2,639	2,741	2,371	2,060	2,032	2,418	1,560	1,651	968	917
Operating Cost of Revenue	2,639	2,741	2,371	2,060	2,032	2,418	1,560	1,651	968	917
Total Operating Expenses	2,425	2,582	2,600	2,381	2,595	2,217	1,484	1,481	853	804
Selling, General & Admin Expense	734	798	719	610	677	683	452	500	302	275
Research & Development Expense	1,097	1,118	989	836	878	826	529	545	373	350
Amortization Expense	605	670	863	932	994	674	486	338	175	177
Other Special Charges / (Income)	-12	-4.00	30	1.70	47	34	18	99	4.00	2.84
Total Other Income / (Expense), net	-205	-206	-367	-659	-497	-510	-199	-186	-71	-80
Interest Expense	211	212	370	657	503	516	215	190	104	113
Interest & Investment Income	7.60	2.10	0.50	1.70	2.80	7.90	22	2.90	24	19
Other Income / (Expense), net	-2.20	3.80	2.80	-3.80	3.20	-2.20	-5.80	1.30	8.90	14
Income Tax Expense	459	672	197	-9.90	-420	-151	482	-81	-43	-19
Basic Earnings per Share	$3.52	$4.07	$2.33	$0.67	$1.19	$1.51	$1.10	$0.76	$1.59	$1.84
Weighted Average Basic Shares Outstanding	542M	550.40M	552.30M	519.20M	477.70M	236.20M	232.90M	217.20M	203.40M	200.94M
Diluted Earnings per Share	$3.48	$4.02	$2.27	$0.65	$1.11	$1.42	$1.03	$0.71	$1.49	$1.65
Weighted Average Diluted Shares Outstanding	548M	557.30M	565.90M	541.20M	512.40M	249.90M	248.90M	234.80M	217.40M	223.56M
Weighted Average Basic & Diluted Shares Outstanding	536.89M	545.38M	554.50M	273.53M	245.33M	235.70M	232.20M	216.60M	203.90M	200.50M
Cash Dividends to Common per Share	$1.68	$1.26	$0.91	$0.75	$0.73	$1.46	$1.45	$1.44	$1.43	$1.43

This table shows Microchip Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-54	78	129	155	419	667	666	604	580	546	507
Consolidated Net Income / (Loss)	-54	78	129	155	419	667	666	604	580	546	507
Net Income / (Loss) Continuing Operations	-54	78	129	155	419	667	666	604	580	546	507
Total Pre-Tax Income	-46	92	162	200	484	834	848	802	762	699	647
Total Operating Income	31	147	219	254	529	885	903	848	812	755	701
Total Gross Profit	561	669	737	790	1,120	1,527	1,558	1,519	1,471	1,398	1,310
Total Revenue	1,026	1,164	1,241	1,326	1,766	2,254	2,289	2,233	2,169	2,073	1,964
Operating Revenue	1,026	1,164	1,241	1,326	1,766	2,254	2,289	2,233	2,169	2,073	1,964
Total Cost of Revenue	465	495	504	536	646	727	730	713	698	675	654
Operating Cost of Revenue	465	495	504	536	646	727	730	713	698	675	654
Total Operating Expenses	531	522	518	536	591	642	655	671	659	643	609
Selling, General & Admin Expense	158	157	151	162	172	197	204	204	203	202	189
Research & Development Expense	246	241	242	240	266	293	299	298	282	269	269
Amortization Expense	123	123	123	151	151	151	152	167	167	168	168
Other Special Charges / (Income)	3.50	1.50	2.60	-17	1.10	1.80	1.70	2.10	6.50	4.30	-17
Total Other Income / (Expense), net	-77	-55	-57	-54	-45	-51	-55	-46	-49	-56	-55
Interest Expense	69	59	62	55	49	50	56	48	53	55	57
Interest & Investment Income	1.70	2.00	2.80	2.50	2.00	1.60	1.50	1.00	0.80	0.20	0.10
Other Income / (Expense), net	-9.70	2.00	1.70	-1.20	2.10	-3.10	0.00	0.30	2.60	-0.80	1.70
Income Tax Expense	7.50	13	33	45	65	167	182	198	182	153	139
Basic Earnings per Share	($0.10)	$0.15	$0.24	$0.29	$0.78	$1.23	$1.22	$1.10	$1.06	$0.99	$0.92
Weighted Average Basic Shares Outstanding	537.40M	536.70M	536.70M	542M	540.80M	543.10M	545.10M	550.40M	549.20M	551.50M	553.80M
Diluted Earnings per Share	($0.10)	$0.14	$0.24	$0.29	$0.77	$1.21	$1.21	$1.10	$1.04	$0.98	$0.90
Weighted Average Diluted Shares Outstanding	537.40M	542M	542.80M	548M	546.50M	549.20M	551.40M	557.30M	555.40M	558.30M	561.50M
Weighted Average Basic & Diluted Shares Outstanding	537.82M	537.01M	536.51M	536.89M	540.39M	541.05M	544.33M	545.38M	547.80M	550.01M	552.48M
Cash Dividends to Common per Share	$0.46	$0.45	$0.45	$0.45	$0.44	$0.41	$0.38	$0.36	$0.33	$0.30	$0.28

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015
Net Change in Cash & Equivalents	86	-83	37	-121	-28	-473	-7.40	-1,183	196	-1,062
Net Cash From Operating Activities	2,893	3,621	2,843	1,917	1,544	1,675	1,420	1,060	468	378
Net Cash From Continuing Operating Activities	2,893	3,621	2,843	1,917	1,544	1,669	1,420	1,060	468	378
Net Income / (Loss) Continuing Operations	1,907	2,238	1,286	349	571	356	255	165	0.00	0.00
Consolidated Net Income / (Loss)	1,907	2,238	1,286	349	571	356	255	165	-	-
Depreciation Expense	880	998	1,144	1,153	1,216	876	616	469	283	278
Amortization Expense	45	17	56	88	139	131	113	61	52	17
Non-Cash Adjustments To Reconcile Net Income	192	181	327	492	176	183	120	197	71	109
Changes in Operating Assets and Liabilities, net	-130	188	31	-166	-557	123	316	168	61	-27
Net Cash From Investing Activities	-392	-600	-478	-173	-133	-6,811	-1,012	-2,838	800	-678
Net Cash From Continuing Investing Activities	-392	-600	-478	-173	-133	-6,811	-1,012	-2,838	14	0.00
Purchase of Property, Plant & Equipment	-399	-600	-492	-182	-139	-248	-214	-86	-	-
Sale of Property, Plant & Equipment	0.40	0.90	14	8.30	3.20	0.20	10	23	14	0.00
Other Investing Activities, net	6.00	0.00	0.00	-	-	-	-	-	-	-
Net Cash From Financing Activities	-2,415	-3,105	-2,328	-1,864	-1,438	4,664	-415	596	-60	99
Net Cash From Continuing Financing Activities	-2,415	-3,105	-2,328	-1,864	-1,438	4,664	-415	596	-286	-1,439
Repayment of Debt	-17,596	-7,405	-6,557	-8,979	-2,716	-4,368	-75	-3,255	-2.20	-1,167
Repurchase of Common Equity	-982	-946	-426	0.00	0.00	-	-	-	-	-
Payment of Dividends	-912	-695	-504	-388	-350	-344	-338	-315	-291	-286
Issuance of Debt	17,055	5,935	5,173	7,544	1,638	9,406	0.00	4,182	0.00	0.00
Issuance of Common Equity	82	82	71	60	59	43	42	42	29	34
Other Financing Activities, net	-63	-77	-85	-101	-69	-73	-44	-58	-22	-20

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	300	-29	-4.60	39	24	-15	37	-55	-16	-72	60
Net Cash From Operating Activities	272	44	377	430	853	616	993	710	1,278	793	840
Net Cash From Continuing Operating Activities	272	44	377	430	853	616	993	710	1,278	793	840
Net Income / (Loss) Continuing Operations	-54	78	129	155	419	667	666	604	580	546	507
Consolidated Net Income / (Loss)	-54	78	129	155	419	667	666	604	580	546	507
Depreciation Expense	187	188	189	218	219	219	223	243	244	252	259
Amortization Expense	25	14	19	20	16	4.90	3.90	4.20	4.20	4.20	4.10
Non-Cash Adjustments To Reconcile Net Income	-76	46	44	43	45	49	54	44	48	41	47
Changes in Operating Assets and Liabilities, net	189	-283	-3.50	-6.50	154	-323	46	-186	402	-50	23
Net Cash From Investing Activities	-42	-64	-126	-71	-86	-94	-141	-151	-164	-131	-154
Net Cash From Continuing Investing Activities	-42	-64	-126	-71	-86	-94	-141	-151	-164	-131	-154
Purchase of Property, Plant & Equipment	-42	-67	-126	-76	-87	-94	-141	-151	-164	-131	-154
Other Investing Activities, net	-0.10	2.40	0.10	4.90	1.10	0.40	0.00	-	-	-	-
Net Cash From Financing Activities	71	-8.40	-256	-320	-743	-537	-815	-614	-1,130	-735	-627
Net Cash From Continuing Financing Activities	71	-8.40	-256	-320	-743	-537	-815	-614	-1,130	-735	-627
Repayment of Debt	-5,883	-2,534	-4,653	-6,896	-2,954	-4,696	-3,050	-2,067	-1,975	-1,784	-1,579
Repurchase of Common Equity	-6.50	-17	-73	-387	-115	-340	-140	-274	-230	-247	-195
Payment of Dividends	-245	-244	-243	-243	-237	-223	-209	-196	-180	-166	-153
Issuance of Debt	6,205	2,781	4,823	7,196	2,563	4,711	2,585	1,914	1,256	1,459	1,306
Issuance of Common Equity	12	21	13	24	17	25	15	28	17	24	13
Other Financing Activities, net	-12	-15	-124	-15	-17	-15	-16	-19	-17	-21	-20

This table presents Microchip Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015
Total Assets	15,873	16,370	16,200	16,479	17,426	18,350	8,257	7,687	5,538	4,781
Total Current Assets	3,013	3,069	2,453	2,145	2,217	2,215	3,356	2,305	3,097	2,665
Cash & Equivalents	320	234	317	280	401	429	901	909	2,093	608
Accounts Receivable	1,144	1,305	1,073	998	934	881	564	478	290	274
Inventories, net	1,316	1,325	854	665	686	712	476	417	307	279
Other Current Assets	234	205	206	201	195	192	120	59	12	47
Plant, Property, & Equipment, net	1,195	1,178	968	855	876	997	768	683	609	582
Total Noncurrent Assets	11,666	12,123	12,779	13,479	14,333	15,139	4,133	4,699	1,832	1,535
Goodwill	6,675	6,674	6,674	6,671	6,665	6,664	2,299	2,299	1,013	571
Intangible Assets	2,782	3,369	4,043	4,795	5,702	6,686	1,662	2,148	606	504
Noncurrent Deferred & Refundable Income Taxes	1,597	1,623	1,797	1,749	1,749	1,677	100	69	15	0.00
Other Noncurrent Operating Assets	612	457	265	264	217	112	72	75	79	76
Total Liabilities & Shareholders' Equity	15,873	16,370	16,200	16,479	17,426	18,350	8,257	7,687	5,538	4,781
Total Liabilities	9,215	9,857	10,305	11,142	11,841	13,063	4,977	4,416	3,387	2,720
Total Current Liabilities	2,519	3,119	1,399	2,410	1,637	2,375	2,017	705	382	354
Short-Term Debt	999	1,398	0.00	1,323	609	1,361	1,310	50	0.00	-
Accounts Payable	213	397	345	292	247	226	144	149	79	87
Accrued Expenses	1,307	1,324	1,054	794	782	787	230	213	119	101
Total Noncurrent Liabilities	6,696	6,738	8,906	8,732	10,203	10,688	2,960	3,712	3,005	2,366
Long-Term Debt	5,000	5,042	7,687	7,581	8,873	8,946	1,758	2,901	2,453	1,827
Noncurrent Deferred Revenue	649	706	705	690	668	756	755	185	111	114
Noncurrent Deferred & Payable Income Tax Liabilities	29	43	40	44	319	706	206	409	399	381
Other Noncurrent Operating Liabilities	1,018	948	474	417	343	280	241	217	41	43
Total Equity & Noncontrolling Interests	6,658	6,514	5,895	5,337	5,586	5,288	3,280	3,271	2,151	2,045
Total Preferred & Common Equity	6,658	6,514	5,895	5,337	5,586	5,288	3,280	3,271	2,151	2,045
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	6,658	6,514	5,895	5,337	5,586	5,288	3,280	3,271	2,151	2,045
Common Stock	2,483	2,414	2,537	2,404	2,675	2,680	2,563	2,538	1,392	1,000
Retained Earnings	6,760	5,764	4,175	3,394	3,432	3,211	1,397	1,479	1,583	1,550
Treasury Stock	-2,582	-1,660	-796	-434	-501	-582	-663	-732	-820	-516
Accumulated Other Comprehensive Income / (Loss)	-3.50	-4.10	-21	-26	-22	-21	-18	-14	-3.36	11

This table presents Microchip Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Total Assets	15,632	15,622	15,840	15,873	16,143	16,601	16,495	16,370	16,116	16,141	16,208
Total Current Assets	2,996	2,906	2,948	3,013	3,220	3,526	3,270	3,069	2,834	2,676	2,643
Cash & Equivalents	586	286	315	320	281	257	271	234	289	305	377
Accounts Receivable	857	1,044	1,096	1,144	1,398	1,706	1,465	1,305	1,175	1,133	1,145
Inventories, net	1,356	1,340	1,308	1,316	1,311	1,331	1,336	1,325	1,165	1,030	912
Other Current Assets	196	236	229	234	229	233	197	205	204	206	207
Plant, Property, & Equipment, net	1,152	1,171	1,196	1,195	1,208	1,207	1,186	1,178	1,114	1,088	995
Total Noncurrent Assets	11,484	11,546	11,695	11,666	11,715	11,868	12,039	12,123	12,169	12,377	12,570
Goodwill	6,685	6,682	6,682	6,675	6,675	6,675	6,675	6,674	6,674	6,674	6,674
Intangible Assets	2,518	2,655	2,776	2,782	2,937	3,089	3,253	3,369	3,545	3,705	3,869
Noncurrent Deferred & Refundable Income Taxes	1,704	1,638	1,601	1,597	1,538	1,576	1,604	1,623	1,630	1,692	1,748
Other Noncurrent Operating Assets	577	572	637	612	565	528	507	457	320	306	280
Total Liabilities & Shareholders' Equity	15,632	15,622	15,840	15,873	16,143	16,601	16,495	16,370	16,116	16,141	16,208
Total Liabilities	9,601	9,346	9,434	9,215	9,063	9,633	9,663	9,857	9,805	10,038	10,231
Total Current Liabilities	1,330	3,286	1,520	2,519	3,293	3,413	3,220	3,119	1,611	2,538	1,485
Short-Term Debt	0.00	1,946	0.00	999	1,662	1,661	1,399	1,398	-	999	-
Accounts Payable	196	204	196	213	242	284	281	397	355	380	305
Accrued Expenses	1,134	1,135	1,324	1,307	1,389	1,468	1,540	1,324	1,256	1,160	1,181
Total Noncurrent Liabilities	8,270	6,061	7,913	6,696	5,770	6,220	6,444	6,738	8,193	7,500	8,745
Long-Term Debt	6,750	4,477	6,168	5,000	4,033	4,415	4,632	5,042	6,589	6,305	7,564
Noncurrent Deferred Revenue	599	590	656	649	635	679	719	706	660	667	706
Noncurrent Deferred & Payable Income Tax Liabilities	23	30	32	29	33	34	42	43	40	42	41
Other Noncurrent Operating Liabilities	899	964	1,058	1,018	1,068	1,093	1,050	948	904	486	434
Total Equity & Noncontrolling Interests	6,032	6,276	6,406	6,658	7,080	6,969	6,831	6,514	6,312	6,103	5,978
Total Preferred & Common Equity	6,032	6,276	6,406	6,658	7,080	6,969	6,831	6,514	6,312	6,103	5,978
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	6,032	6,276	6,406	6,658	7,080	6,969	6,831	6,514	6,312	6,103	5,978
Common Stock	2,482	2,446	2,405	2,483	2,446	2,415	2,401	2,414	2,381	2,356	2,394
Retained Earnings	6,183	6,481	6,646	6,760	6,847	6,666	6,222	5,764	5,356	4,956	4,576
Treasury Stock	-2,630	-2,643	-2,641	-2,582	-2,209	-2,109	-1,787	-1,660	-1,408	-1,197	-975
Accumulated Other Comprehensive Income / (Loss)	-3.30	-7.80	-3.70	-3.50	-4.80	-2.80	-4.40	-4.10	-18	-12	-17

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-9.53%	23.72%	25.42%	3.11%	-1.41%	34.38%	16.81%	56.80%	1.22%	11.18%
EBITDA Growth	-15.52%	35.47%	36.52%	11.53%	16.59%	3.62%	105.65%	15.87%	-5.24%	10.54%
EBIT Growth	-17.66%	68.42%	86.30%	52.90%	-8.68%	-23.47%	235.80%	-23.28%	-17.79%	-5.47%
NOPAT Growth	-13.53%	49.42%	56.13%	-58.16%	97.49%	283.29%	-38.10%	29.16%	-9.76%	7.15%
Net Income Growth	-14.78%	74.07%	267.92%	-38.77%	60.33%	39.35%	55.16%	-49.18%	-11.34%	-7.58%
EPS Growth	-13.43%	77.09%	249.23%	-38.77%	60.33%	37.86%	45.07%	-52.35%	-9.70%	-9.34%
Operating Cash Flow Growth	-20.11%	27.38%	48.33%	24.14%	-7.82%	17.98%	33.99%	126.53%	23.89%	45.51%
Free Cash Flow Firm Growth	-16.53%	27.80%	32.75%	-41.34%	130.24%	-1,099.55%	143.62%	-1,305.39%	-1,184.88%	-102.54%
Invested Capital Growth	-3.00%	-4.10%	-4.99%	-4.81%	-3.29%	265.26%	-13.59%	135.54%	38.32%	45.61%
Revenue Q/Q Growth	-10.62%	4.83%	5.85%	2.66%	-0.06%	6.52%	2.57%	11.27%	0.67%	2.38%
EBITDA Q/Q Growth	-14.76%	6.20%	8.61%	4.79%	-2.78%	9.63%	7.20%	21.85%	-5.62%	5.08%
EBIT Q/Q Growth	-18.83%	10.62%	15.01%	16.80%	-16.75%	9.88%	8.75%	38.75%	-11.94%	0.41%
NOPAT Q/Q Growth	-17.54%	6.22%	18.79%	-12.74%	26.20%	35.88%	-3.11%	94.50%	-14.74%	8.29%
Net Income Q/Q Growth	-19.07%	8.02%	33.41%	4.83%	-11.59%	8.54%	4.00%	73.15%	-8.80%	-3.41%
EPS Q/Q Growth	-20.18%	6.63%	30.46%	4.83%	-11.59%	2.16%	-0.96%	86.84%	-8.02%	-4.07%
Operating Cash Flow Q/Q Growth	-8.81%	-1.04%	11.73%	4.21%	-2.01%	2.69%	2.67%	59.88%	24.15%	14.78%
Free Cash Flow Firm Q/Q Growth	-6.69%	-2.04%	11.71%	-9.12%	22.18%	3.40%	-9.55%	13.19%	38.90%	-115.48%
Invested Capital Q/Q Growth	-1.25%	0.86%	-0.70%	-0.75%	-0.88%	-0.68%	-2.08%	-3.63%	-4.46%	5.47%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	65.44%	67.52%	65.23%	62.13%	61.47%	54.80%	60.81%	51.56%	55.47%	57.27%
EBITDA Margin	45.75%	49.00%	44.75%	41.11%	38.01%	32.14%	41.69%	23.68%	32.04%	34.23%
Operating Margin	33.68%	36.93%	27.12%	18.35%	12.27%	13.35%	23.52%	8.09%	16.21%	19.82%
EBIT Margin	33.65%	36.97%	27.16%	18.28%	12.33%	13.31%	23.37%	8.13%	16.62%	20.46%
Profit (Net Income) Margin	24.98%	26.52%	18.85%	6.42%	10.82%	6.65%	6.42%	4.83%	14.90%	17.02%
Tax Burden Percent	80.60%	76.90%	86.71%	102.92%	379.39%	174.03%	34.64%	183.30%	115.14%	105.61%
Interest Burden Percent	92.10%	93.27%	80.03%	34.14%	23.13%	28.72%	79.24%	32.41%	77.88%	78.73%
Effective Tax Rate	19.40%	23.10%	13.29%	-2.92%	-279.39%	-74.03%	65.36%	-89.98%	-15.14%	-5.61%
Return on Invested Capital (ROIC)	16.54%	18.45%	11.78%	7.18%	16.46%	12.87%	7.24%	15.31%	23.09%	36.14%
ROIC Less NNEP Spread (ROIC-NNEP)	13.76%	16.11%	7.80%	-0.48%	-3.42%	-3.64%	1.51%	-35.21%	47.09%	46.09%
Return on Net Nonoperating Assets (RNNOA)	12.42%	17.62%	11.11%	-0.78%	-5.97%	-4.56%	0.56%	-9.24%	-7.65%	-18.66%
Return on Equity (ROE)	28.96%	36.07%	22.89%	6.40%	10.50%	8.31%	7.80%	6.07%	15.44%	17.48%
Cash Return on Invested Capital (CROIC)	19.59%	22.63%	16.90%	12.11%	19.81%	-101.15%	21.83%	-65.48%	-9.07%	-1.00%
Operating Return on Assets (OROA)	15.93%	19.16%	11.34%	5.87%	3.64%	5.35%	11.67%	4.19%	7.00%	9.93%
Return on Assets (ROA)	11.83%	13.74%	7.87%	2.06%	3.19%	2.68%	3.20%	2.49%	6.28%	8.26%
Return on Common Equity (ROCE)	28.96%	36.07%	22.89%	6.40%	10.50%	8.31%	7.80%	6.07%	15.44%	17.48%
Return on Equity Simple (ROE_SIMPLE)	28.64%	34.35%	21.81%	6.55%	10.22%	6.73%	7.79%	5.03%	15.06%	17.87%
Net Operating Profit after Tax (NOPAT)	2,072	2,396	1,604	1,027	2,455	1,243	324	524	406	450
NOPAT Margin	27.14%	28.40%	23.51%	18.89%	46.55%	23.24%	8.15%	15.38%	18.67%	20.94%
Net Nonoperating Expense Percent (NNEP)	2.78%	2.34%	3.98%	7.66%	19.88%	16.51%	5.73%	50.52%	-24.00%	-9.95%
Cost of Revenue to Revenue	34.56%	32.48%	34.77%	37.87%	38.53%	45.20%	39.19%	48.44%	44.53%	42.73%
SG&A Expenses to Revenue	9.62%	9.45%	10.54%	11.22%	12.83%	12.77%	11.36%	14.67%	13.88%	12.80%
R&D to Revenue	14.37%	13.25%	14.50%	15.38%	16.64%	15.45%	13.30%	16.00%	17.14%	16.28%
Operating Expenses to Revenue	31.76%	30.60%	38.12%	43.78%	49.20%	41.44%	37.29%	43.47%	39.26%	37.44%
Earnings before Interest and Taxes (EBIT)	2,569	3,120	1,852	994	650	712	931	277	361	439
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3,493	4,135	3,052	2,236	2,005	1,719	1,659	807	696	735
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.21	6.83	6.76	7.37	2.70	3.40	5.87	4.32	3.94	4.03
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.91	8.50
Price to Revenue (P/Rev)	6.29	5.27	5.84	7.24	2.86	3.36	4.84	4.14	3.89	3.84
Price to Earnings (P/E)	25.16	19.89	30.98	112.63	26.45	50.53	75.38	85.74	26.12	22.32
Dividend Yield	1.89%	1.55%	1.27%	1.02%	2.33%	1.92%	1.76%	2.21%	3.45%	3.49%
Earnings Yield	3.97%	5.03%	3.23%	0.89%	3.78%	1.98%	1.33%	1.17%	3.83%	4.48%
Enterprise Value to Invested Capital (EV/IC)	4.35	3.99	3.56	3.44	1.65	1.84	4.85	3.26	4.10	5.24
Enterprise Value to Revenue (EV/Rev)	7.03	6.01	6.92	8.82	4.58	5.21	5.06	4.59	3.84	3.60
Enterprise Value to EBITDA (EV/EBITDA)	15.36	12.26	15.46	21.46	12.06	16.20	12.13	19.40	11.99	10.51
Enterprise Value to EBIT (EV/EBIT)	20.89	16.25	25.47	48.25	37.17	39.13	21.63	56.49	23.13	17.57
Enterprise Value to NOPAT (EV/NOPAT)	25.90	21.16	29.42	46.71	9.85	22.41	62.04	29.88	20.59	17.18
Enterprise Value to Operating Cash Flow (EV/OCF)	18.55	14.00	16.60	25.03	15.66	16.64	14.18	14.77	17.86	20.45
Enterprise Value to Free Cash Flow (EV/FCFF)	21.87	17.25	20.52	27.69	8.18	0.00	20.59	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.90	0.99	1.30	1.67	1.70	1.95	0.94	0.90	1.14	0.89
Long-Term Debt to Equity	0.75	0.77	1.30	1.42	1.59	1.69	0.54	0.89	1.14	0.89
Financial Leverage	0.90	1.09	1.42	1.62	1.74	1.25	0.37	0.26	-0.16	-0.41
Leverage Ratio	2.45	2.62	2.91	3.10	3.29	3.11	2.43	2.44	2.46	2.12
Compound Leverage Factor	2.25	2.45	2.33	1.06	0.76	0.89	1.93	0.79	1.92	1.67
Debt to Total Capital	47.40%	49.72%	56.60%	62.52%	62.93%	66.09%	48.33%	47.43%	53.28%	47.19%
Short-Term Debt to Total Capital	7.90%	10.79%	0.00%	9.29%	4.04%	8.73%	20.63%	0.80%	0.00%	0.00%
Long-Term Debt to Total Capital	39.51%	38.92%	56.60%	53.23%	58.89%	57.37%	27.70%	46.62%	53.28%	47.19%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.60%	50.28%	43.40%	37.48%	37.07%	33.91%	51.67%	52.57%	46.72%	52.81%
Debt to EBITDA	1.72	1.56	2.52	3.98	4.73	5.99	1.85	3.66	3.52	2.49
Net Debt to EBITDA	1.63	1.50	2.41	3.86	4.53	5.74	0.53	1.91	-0.16	-0.70
Long-Term Debt to EBITDA	1.43	1.22	2.52	3.39	4.43	5.20	1.06	3.59	3.52	2.49
Debt to NOPAT	2.90	2.69	4.79	8.67	3.86	8.29	9.46	5.63	6.05	4.06
Net Debt to NOPAT	2.74	2.59	4.59	8.39	3.70	7.94	2.69	2.94	-0.27	-1.15
Long-Term Debt to NOPAT	2.41	2.10	4.79	7.38	3.61	7.20	5.42	5.54	6.05	4.06
Altman Z-Score	4.77	4.34	3.56	2.92	1.51	1.48	3.61	3.00	3.10	3.60
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.20	0.98	1.75	0.89	1.35	0.93	1.66	3.27	8.11	7.53
Quick Ratio	0.58	0.49	1.00	0.53	0.82	0.55	1.37	2.53	7.16	6.31
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	2,454	2,940	2,300	1,733	2,954	-9,769	977	-2,241	-159	-12
Operating Cash Flow to CapEx	726.63%	604.00%	595.08%	1,105.89%	1,135.98%	677.23%	697.25%	1,695.20%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	11.66	13.85	6.21	2.64	5.88	-18.95	4.55	-11.78	-1.53	-0.11
Operating Cash Flow to Interest Expense	13.74	17.06	7.67	2.92	3.07	3.25	6.60	5.57	4.50	3.35
Operating Cash Flow Less CapEx to Interest Expense	11.85	14.24	6.39	2.66	2.80	2.77	5.66	5.24	4.63	3.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.47	0.52	0.42	0.32	0.29	0.40	0.50	0.52	0.42	0.49
Accounts Receivable Turnover	6.23	7.10	6.59	5.63	5.81	7.41	7.64	8.87	7.71	8.32
Inventory Turnover	2.00	2.52	3.12	3.05	2.91	4.07	3.49	4.56	3.30	3.38
Fixed Asset Turnover	6.44	7.87	7.48	6.28	5.63	6.06	5.49	5.27	3.65	3.86
Accounts Payable Turnover	8.65	7.39	7.44	7.64	8.59	13.05	10.64	14.45	11.65	11.40
Days Sales Outstanding (DSO)	58.54	51.43	55.39	64.82	62.79	49.27	47.78	41.16	47.37	43.89
Days Inventory Outstanding (DIO)	182.65	145.11	116.94	119.68	125.50	89.65	104.51	80.05	110.55	107.85
Days Payable Outstanding (DPO)	42.18	49.38	49.03	47.78	42.50	27.96	34.31	25.27	31.34	32.01
Cash Conversion Cycle (CCC)	199.01	147.16	123.30	136.73	145.79	110.96	117.97	95.95	126.59	119.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	12,338	12,720	13,263	13,959	14,665	15,164	4,152	4,805	2,040	1,475
Invested Capital Turnover	0.61	0.65	0.50	0.38	0.35	0.55	0.89	1.00	1.24	1.73
Increase / (Decrease) in Invested Capital	-382	-543	-696	-706	-499	11,012	-653	2,765	565	462
Enterprise Value (EV)	53,667	50,705	47,190	47,977	24,174	27,861	20,123	15,654	8,353	7,721
Market Capitalization	47,987	44,499	39,822	39,355	15,094	17,985	19,251	14,114	8,464	8,236
Book Value per Share	$12.32	$11.89	$10.60	$19.82	$23.32	$22.31	$14.00	$15.11	$10.57	$10.15
Tangible Book Value per Share	($5.18)	($6.44)	($8.67)	($22.76)	($28.31)	($34.02)	($2.91)	($5.44)	$2.61	$4.81
Total Capital	12,658	12,954	13,582	14,241	15,068	15,595	6,348	6,221	4,604	3,872
Total Debt	6,000	6,440	7,687	8,904	9,482	10,307	3,068	2,951	2,453	1,827
Total Long-Term Debt	5,000	5,042	7,687	7,581	8,873	8,946	1,758	2,901	2,453	1,827
Net Debt	5,680	6,206	7,368	8,622	9,079	9,876	872	1,540	-111	-515
Capital Expenditures (CapEx)	398	600	478	173	136	247	204	63	-14	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,173	1,115	734	777	786	770	452	348	269	352
Debt-free Net Working Capital (DFNWC)	1,493	1,349	1,054	1,059	1,189	1,201	2,649	1,651	2,715	2,311
Net Working Capital (NWC)	494	-49	1,054	-264	580	-160	1,339	1,601	2,715	2,311
Net Nonoperating Expense (NNE)	165	159	318	678	1,884	887	69	359	82	84
Net Nonoperating Obligations (NNO)	5,680	6,206	7,368	8,622	9,079	9,876	872	1,534	-111	-570
Total Depreciation and Amortization (D&A)	924	1,015	1,200	1,242	1,354	1,007	729	530	335	296
Debt-free, Cash-free Net Working Capital to Revenue	15.37%	13.21%	10.76%	14.28%	14.90%	14.40%	11.36%	10.20%	12.36%	16.38%
Debt-free Net Working Capital to Revenue	19.56%	15.98%	15.45%	19.46%	22.54%	22.45%	66.54%	48.43%	124.91%	107.62%
Net Working Capital to Revenue	6.47%	-0.58%	15.45%	-4.86%	10.99%	-2.99%	33.63%	46.97%	124.91%	107.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.52	$4.07	$2.33	$0.68	$1.20	$0.76	$0.55	$0.38	$0.80	$0.92
Adjusted Weighted Average Basic Shares Outstanding	542M	550.40M	552.30M	519.20M	477.80M	472.40M	465.80M	434.39M	406.77M	401.87M
Adjusted Diluted Earnings per Share	$3.48	$4.02	$2.27	$0.65	$1.12	$0.71	$0.52	$0.36	$0.75	$0.83
Adjusted Weighted Average Diluted Shares Outstanding	548M	557.30M	565.90M	541.20M	512.40M	499.80M	497.80M	469.61M	434.78M	447.12M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.76	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	536.89M	545.38M	554.50M	547.06M	490.66M	475.85M	470.07M	458.80M	429.63M	404.65M
Normalized Net Operating Profit after Tax (NOPAT)	2,062	2,393	1,629	700	486	524	668	262	249	300
Normalized NOPAT Margin	27.01%	28.36%	23.89%	12.87%	9.21%	9.79%	16.77%	7.69%	11.48%	13.97%
Pre Tax Income Margin	30.99%	34.48%	21.73%	6.24%	2.85%	3.82%	18.52%	2.64%	12.94%	16.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.20	14.70	5.00	1.51	1.29	1.38	4.33	1.46	3.47	3.90
NOPAT to Interest Expense	9.84	11.29	4.33	1.56	4.88	2.41	1.51	2.75	3.90	3.99
EBIT Less CapEx to Interest Expense	10.31	11.88	3.71	1.25	1.02	0.90	3.38	1.13	3.61	3.90
NOPAT Less CapEx to Interest Expense	7.95	8.47	3.04	1.30	4.61	1.93	0.56	2.43	4.04	3.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	47.80%	31.07%	39.19%	111.13%	61.36%	96.77%	132.15%	191.62%	89.87%	78.42%
Augmented Payout Ratio	99.30%	73.34%	72.30%	111.13%	61.36%	96.77%	132.15%	191.62%	89.87%	78.42%

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-41.89%	-48.37%	-45.76%	-40.62%	-18.60%	8.74%	16.55%	21.07%	23.43%	25.66%	25.12%
EBITDA Growth	-69.57%	-68.35%	-62.11%	-55.21%	-27.84%	9.45%	16.91%	28.26%	27.43%	42.96%	46.97%
EBIT Growth	-96.01%	-83.15%	-75.55%	-70.26%	-34.72%	16.92%	28.46%	54.57%	56.70%	81.89%	90.36%
NOPAT Growth	-95.28%	-82.25%	-75.32%	-69.26%	-25.84%	19.96%	28.97%	27.22%	50.15%	55.06%	75.24%
Net Income Growth	-112.79%	-88.24%	-80.60%	-74.39%	-27.76%	22.04%	31.39%	37.93%	64.48%	125.70%	100.63%
EPS Growth	-112.99%	-88.43%	-80.17%	-73.64%	-25.96%	23.47%	34.44%	39.24%	67.74%	127.91%	100.00%
Operating Cash Flow Growth	-68.18%	-92.92%	-62.03%	-39.39%	-33.23%	-22.31%	18.18%	-5.11%	49.74%	29.67%	33.42%
Free Cash Flow Firm Growth	-44.14%	-50.91%	-60.40%	-51.11%	-57.81%	-10.41%	10.92%	-1.37%	21.62%	15.79%	16.23%
Invested Capital Growth	-2.40%	-2.93%	-2.64%	-3.00%	-0.93%	-2.38%	-4.34%	-4.10%	-5.58%	-4.02%	-4.39%
Revenue Q/Q Growth	-11.84%	-6.24%	-6.37%	-24.91%	-21.67%	-1.50%	2.50%	2.93%	4.63%	5.58%	6.47%
EBITDA Q/Q Growth	-33.34%	-18.24%	-12.78%	-35.98%	-30.67%	-2.13%	3.12%	3.13%	5.16%	4.53%	13.13%
EBIT Q/Q Growth	-85.73%	-32.70%	-12.49%	-52.53%	-39.73%	-2.35%	6.46%	4.19%	7.94%	7.30%	28.10%
NOPAT Q/Q Growth	-82.78%	-28.26%	-10.84%	-57.15%	-35.25%	-0.25%	11.06%	3.38%	4.74%	7.24%	9.55%
Net Income Q/Q Growth	-168.37%	-39.37%	-16.42%	-63.10%	-37.11%	0.03%	10.33%	4.08%	6.24%	7.69%	15.83%
EPS Q/Q Growth	-171.43%	-41.67%	-17.24%	-62.34%	-36.36%	0.00%	10.00%	5.77%	6.12%	8.89%	13.92%
Operating Cash Flow Q/Q Growth	522.71%	-88.44%	-12.30%	-49.61%	38.48%	-37.96%	39.99%	-44.48%	61.11%	-5.62%	12.40%
Free Cash Flow Firm Q/Q Growth	-35.83%	-1.32%	-12.23%	0.51%	-43.61%	-20.40%	8.38%	-13.26%	19.72%	-1.44%	-3.63%
Invested Capital Q/Q Growth	-1.75%	1.26%	-0.64%	-1.25%	-2.29%	1.56%	-1.01%	0.86%	-3.73%	-0.48%	-0.75%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.72%	57.44%	59.37%	59.58%	63.43%	67.76%	68.09%	68.05%	67.80%	67.43%	66.71%
EBITDA Margin	22.74%	30.07%	34.49%	37.02%	43.42%	49.05%	49.37%	49.08%	48.98%	48.73%	49.22%
Operating Margin	3.01%	12.60%	17.65%	19.12%	29.98%	39.26%	39.46%	37.98%	37.41%	36.42%	35.72%
EBIT Margin	2.07%	12.77%	17.79%	19.03%	30.10%	39.12%	39.46%	37.99%	37.53%	36.38%	35.80%
Profit (Net Income) Margin	-5.22%	6.74%	10.42%	11.67%	23.74%	29.57%	29.12%	27.05%	26.75%	26.35%	25.83%
Tax Burden Percent	116.27%	85.68%	79.91%	77.47%	86.56%	79.97%	78.56%	75.33%	76.13%	78.13%	78.44%
Interest Burden Percent	-217.45%	61.57%	73.28%	79.15%	91.12%	94.52%	93.93%	94.52%	93.61%	92.68%	91.98%
Effective Tax Rate	0.00%	14.32%	20.09%	22.53%	13.44%	20.03%	21.44%	24.67%	23.87%	21.87%	21.56%
Return on Invested Capital (ROIC)	0.81%	4.71%	7.48%	9.03%	17.66%	21.69%	21.10%	18.59%	17.66%	16.25%	15.01%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.49%	3.92%	6.69%	8.32%	16.99%	21.05%	20.43%	18.07%	17.12%	15.67%	14.46%
Return on Net Nonoperating Assets (RNNOA)	-0.43%	3.54%	5.87%	7.51%	14.86%	20.64%	20.65%	19.77%	19.57%	19.83%	19.40%
Return on Equity (ROE)	0.38%	8.25%	13.35%	16.54%	32.52%	42.34%	41.75%	38.35%	37.24%	36.08%	34.41%
Cash Return on Invested Capital (CROIC)	6.42%	10.58%	15.06%	19.59%	20.95%	23.07%	24.29%	22.63%	23.11%	19.44%	18.11%
Operating Return on Assets (OROA)	0.62%	4.36%	7.25%	9.01%	15.94%	21.37%	21.15%	19.69%	18.79%	17.18%	15.90%
Return on Assets (ROA)	-1.56%	2.30%	4.24%	5.53%	12.57%	16.16%	15.61%	14.02%	13.39%	12.44%	11.47%
Return on Common Equity (ROCE)	0.38%	8.25%	13.35%	16.54%	32.52%	42.34%	41.75%	38.35%	37.24%	36.08%	34.41%
Return on Equity Simple (ROE_SIMPLE)	5.12%	12.45%	21.38%	0.00%	33.28%	36.12%	35.09%	0.00%	32.82%	30.22%	25.76%
Net Operating Profit after Tax (NOPAT)	22	126	175	196	458	708	709	639	618	590	550
NOPAT Margin	2.11%	10.79%	14.11%	14.81%	25.95%	31.39%	31.00%	28.61%	28.49%	28.46%	28.02%
Net Nonoperating Expense Percent (NNEP)	1.30%	0.79%	0.79%	0.70%	0.67%	0.64%	0.67%	0.51%	0.54%	0.59%	0.56%
Return On Investment Capital (ROIC_SIMPLE)	0.17%	-	-	-	3.59%	-	-	-	-	-	-
Cost of Revenue to Revenue	45.28%	42.56%	40.63%	40.42%	36.57%	32.25%	31.91%	31.95%	32.20%	32.57%	33.29%
SG&A Expenses to Revenue	15.42%	13.49%	12.12%	12.20%	9.75%	8.72%	8.90%	9.11%	9.35%	9.76%	9.62%
R&D to Revenue	24.00%	20.68%	19.47%	18.12%	15.06%	12.98%	13.04%	13.36%	13.02%	12.96%	13.70%
Operating Expenses to Revenue	51.71%	44.84%	41.71%	40.46%	33.45%	28.50%	28.63%	30.07%	30.39%	31.01%	30.99%
Earnings before Interest and Taxes (EBIT)	21	149	221	252	532	882	903	848	814	754	703
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	233	350	428	491	767	1,106	1,130	1,096	1,062	1,010	967
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.11	6.86	7.63	7.21	6.74	5.97	6.97	6.83	5.91	5.31	5.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	6.47	7.84	7.42	6.29	5.59	4.65	5.43	5.27	4.63	4.24	4.27
Price to Earnings (P/E)	99.73	55.11	35.67	25.16	20.25	16.53	19.86	19.89	18.01	17.58	20.02
Dividend Yield	3.16%	2.24%	1.92%	1.89%	1.80%	1.93%	1.57%	1.55%	1.71%	1.81%	1.76%
Earnings Yield	1.00%	1.81%	2.80%	3.97%	4.94%	6.05%	5.03%	5.03%	5.55%	5.69%	5.00%
Enterprise Value to Invested Capital (EV/IC)	3.03	3.96	4.46	4.35	4.25	3.71	4.24	3.99	3.46	3.01	2.89
Enterprise Value to Revenue (EV/Rev)	7.77	8.95	8.31	7.03	6.22	5.30	6.09	6.01	5.42	5.16	5.27
Enterprise Value to EBITDA (EV/EBITDA)	24.60	24.18	19.60	15.36	12.96	10.79	12.42	12.26	11.20	10.75	11.31
Enterprise Value to EBIT (EV/EBIT)	57.49	42.68	29.00	20.89	16.79	13.76	16.08	16.25	15.46	15.60	17.39
Enterprise Value to NOPAT (EV/NOPAT)	74.92	51.38	35.55	25.90	21.14	17.74	20.88	21.16	19.33	19.21	20.73
Enterprise Value to Operating Cash Flow (EV/OCF)	32.94	28.88	24.03	18.55	16.75	13.19	14.14	14.00	11.92	12.18	12.45
Enterprise Value to Free Cash Flow (EV/FCFF)	46.61	36.92	29.24	21.87	20.20	15.88	17.06	17.25	14.53	15.16	15.59
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.12	1.02	0.96	0.90	0.80	0.87	0.88	0.99	1.04	1.20	1.27
Long-Term Debt to Equity	1.12	0.71	0.96	0.75	0.57	0.63	0.68	0.77	1.04	1.03	1.27
Financial Leverage	0.88	0.90	0.88	0.90	0.87	0.98	1.01	1.09	1.14	1.27	1.34
Leverage Ratio	2.42	2.43	2.44	2.45	2.41	2.50	2.55	2.62	2.65	2.74	2.83
Compound Leverage Factor	-5.27	1.50	1.79	1.94	2.19	2.37	2.40	2.48	2.49	2.54	2.60
Debt to Total Capital	52.81%	50.58%	49.05%	47.40%	44.58%	46.58%	46.89%	49.72%	51.07%	54.48%	55.86%
Short-Term Debt to Total Capital	0.00%	15.33%	0.00%	7.90%	13.01%	12.73%	10.87%	10.79%	0.00%	7.45%	0.00%
Long-Term Debt to Total Capital	52.81%	35.25%	49.05%	39.51%	31.57%	33.84%	36.01%	38.92%	51.07%	47.03%	55.86%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	47.19%	49.42%	50.95%	52.60%	55.42%	53.42%	53.11%	50.28%	48.93%	45.52%	44.14%
Debt to EBITDA	4.49	3.16	2.21	1.72	1.39	1.38	1.40	1.56	1.69	1.99	2.25
Net Debt to EBITDA	4.10	3.01	2.10	1.63	1.32	1.32	1.34	1.50	1.62	1.91	2.14
Long-Term Debt to EBITDA	4.49	2.20	2.21	1.43	0.98	1.00	1.08	1.22	1.69	1.72	2.25
Debt to NOPAT	13.68	6.71	4.01	2.90	2.27	2.27	2.36	2.69	2.92	3.56	4.12
Net Debt to NOPAT	12.49	6.41	3.80	2.74	2.15	2.18	2.25	2.59	2.79	3.41	3.92
Long-Term Debt to NOPAT	13.68	4.67	4.01	2.41	1.61	1.65	1.81	2.10	2.92	3.07	4.12
Altman Z-Score	2.92	3.70	4.26	4.29	4.38	3.88	4.20	3.88	3.51	3.00	2.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.25	0.88	1.94	1.20	0.98	1.03	1.02	0.98	1.76	1.05	1.78
Quick Ratio	1.08	0.40	0.93	0.58	0.51	0.58	0.54	0.49	0.91	0.57	1.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	321	501	507	578	575	1,020	1,281	1,182	1,363	1,138	1,155
Operating Cash Flow to CapEx	644.89%	65.47%	300.24%	565.05%	977.43%	656.23%	704.90%	470.49%	778.73%	606.42%	546.42%
Free Cash Flow to Firm to Interest Expense	4.66	8.47	8.21	10.49	11.69	20.44	22.76	24.89	25.81	20.55	20.44
Operating Cash Flow to Interest Expense	3.93	0.74	6.10	7.80	17.34	12.35	17.64	14.94	24.20	14.32	14.87
Operating Cash Flow Less CapEx to Interest Expense	3.32	-0.39	4.07	6.42	15.57	10.47	15.14	11.76	21.09	11.96	12.15
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.30	0.34	0.41	0.47	0.53	0.55	0.54	0.52	0.50	0.47	0.44
Accounts Receivable Turnover	4.22	4.00	5.14	6.23	6.64	6.30	6.72	7.10	7.65	7.21	6.73
Inventory Turnover	1.50	1.63	1.82	2.00	2.27	2.43	2.51	2.52	2.74	2.93	3.09
Fixed Asset Turnover	4.03	4.62	5.53	6.44	7.36	7.79	8.04	7.87	7.88	7.59	7.65
Accounts Payable Turnover	9.13	8.95	10.10	8.65	9.43	8.65	9.62	7.39	8.08	7.49	8.36
Days Sales Outstanding (DSO)	86.53	91.32	70.95	58.54	54.98	57.93	54.35	51.43	47.72	50.62	54.27
Days Inventory Outstanding (DIO)	243.38	223.43	200.01	182.65	160.49	150.20	145.63	145.11	133.10	124.47	118.22
Days Payable Outstanding (DPO)	39.97	40.80	36.13	42.18	38.69	42.19	37.96	49.38	45.16	48.70	43.65
Cash Conversion Cycle (CCC)	289.93	273.95	234.83	199.01	176.78	165.94	162.03	147.16	135.66	126.38	128.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	12,195	12,413	12,259	12,338	12,495	12,788	12,591	12,720	12,611	13,100	13,163
Invested Capital Turnover	0.39	0.44	0.53	0.61	0.68	0.69	0.68	0.65	0.62	0.57	0.54
Increase / (Decrease) in Invested Capital	-300	-375	-332	-382	-117	-312	-572	-543	-745	-548	-605
Enterprise Value (EV)	36,961	49,213	54,709	53,667	53,122	47,430	53,368	50,705	43,605	39,407	38,012
Market Capitalization	30,798	43,076	48,856	47,987	47,708	41,611	47,608	44,499	37,305	32,411	30,827
Book Value per Share	$11.23	$11.70	$11.93	$12.32	$13.09	$12.80	$12.53	$11.89	$11.48	$11.05	$10.78
Tangible Book Value per Share	($5.91)	($5.70)	($5.68)	($5.18)	($4.68)	($5.14)	($5.68)	($6.44)	($7.10)	($7.74)	($8.23)
Total Capital	12,781	12,699	12,574	12,658	12,776	13,044	12,862	12,954	12,900	13,407	13,542
Total Debt	6,750	6,423	6,168	6,000	5,695	6,076	6,031	6,440	6,589	7,304	7,564
Total Long-Term Debt	6,750	4,477	6,168	5,000	4,033	4,415	4,632	5,042	6,589	6,305	7,564
Net Debt	6,164	6,137	5,853	5,680	5,414	5,819	5,760	6,206	6,300	6,997	7,185
Capital Expenditures (CapEx)	42	67	126	76	87	94	141	151	164	131	154
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1,080	1,280	1,113	1,173	1,308	1,518	1,178	1,115	934	829	779
Debt-free Net Working Capital (DFNWC)	1,666	1,566	1,428	1,493	1,589	1,775	1,449	1,349	1,223	1,136	1,158
Net Working Capital (NWC)	1,666	-380	1,428	494	-74	114	50	-49	1,223	138	1,158
Net Nonoperating Expense (NNE)	75	47	46	42	39	41	43	35	38	44	43
Net Nonoperating Obligations (NNO)	6,164	6,137	5,853	5,680	5,414	5,819	5,760	6,206	6,300	6,997	7,185
Total Depreciation and Amortization (D&A)	212	201	207	239	235	224	227	247	248	256	264
Debt-free, Cash-free Net Working Capital to Revenue	22.69%	23.29%	16.90%	15.37%	15.31%	16.97%	13.44%	13.21%	11.60%	10.86%	10.79%
Debt-free Net Working Capital to Revenue	35.01%	28.49%	21.68%	19.56%	18.60%	19.84%	16.53%	15.98%	15.19%	14.87%	16.05%
Net Working Capital to Revenue	35.01%	-6.92%	21.68%	6.47%	-0.86%	1.27%	0.57%	-0.58%	15.19%	1.80%	16.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.10)	$0.15	$0.24	$0.29	$0.78	$1.23	$1.22	$1.10	$1.06	$0.99	$0.92
Adjusted Weighted Average Basic Shares Outstanding	537.40M	536.70M	536.70M	542M	540.80M	543.10M	545.10M	550.40M	549.20M	551.50M	553.80M
Adjusted Diluted Earnings per Share	($0.10)	$0.14	$0.24	$0.29	$0.77	$1.21	$1.21	$1.10	$1.04	$0.98	$0.90
Adjusted Weighted Average Diluted Shares Outstanding	537.40M	542M	542.80M	548M	546.50M	549.20M	551.40M	557.30M	555.40M	558.30M	561.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.10	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	537.82M	537.01M	536.51M	536.89M	540.39M	541.05M	544.33M	545.38M	547.80M	550.01M	552.48M
Normalized Net Operating Profit after Tax (NOPAT)	24	127	177	183	459	709	711	640	623	593	537
Normalized NOPAT Margin	2.35%	10.90%	14.27%	13.82%	26.01%	31.46%	31.06%	28.68%	28.71%	28.62%	27.34%
Pre Tax Income Margin	-4.49%	7.86%	13.03%	15.06%	27.43%	36.98%	37.07%	35.91%	35.14%	33.72%	32.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.31	2.51	3.57	4.58	10.80	17.67	16.04	17.86	15.42	13.62	12.44
NOPAT to Interest Expense	0.31	2.13	2.83	3.56	9.31	14.18	12.60	13.45	11.70	10.65	9.74
EBIT Less CapEx to Interest Expense	-0.30	1.39	1.54	3.20	9.03	15.79	13.54	14.68	12.31	11.25	9.72
NOPAT Less CapEx to Interest Expense	-0.30	1.00	0.80	2.18	7.54	12.30	10.10	10.27	8.59	8.29	7.01
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	315.22%	123.62%	69.00%	47.80%	36.71%	32.09%	31.34%	31.07%	30.90%	31.92%	35.31%
Augmented Payout Ratio	471.92%	199.36%	135.76%	99.30%	73.57%	71.16%	68.51%	73.34%	75.87%	78.99%	75.62%

Frequently Asked Questions About Microchip Technology's Financials

When does Microchip Technology's fiscal year end?

According to the most recent income statement we have on file, Microchip Technology's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Microchip Technology's net income changed over the last 9 years?

Microchip Technology's net income appears to be on an upward trend, with a most recent value of $1.91 billion in 2024, rising from $365.33 million in 2015. The previous period was $2.24 billion in 2023. View Microchip Technology's forecast to see where analysts expect Microchip Technology to go next.

What is Microchip Technology's operating income?

Microchip Technology's total operating income in 2024 was $2.57 billion, based on the following breakdown:

Total Gross Profit: $5.00 billion
Total Operating Expenses: $2.42 billion

How has Microchip Technology revenue changed over the last 9 years?

Over the last 9 years, Microchip Technology's total revenue changed from $2.15 billion in 2015 to $7.63 billion in 2024, a change of 255.6%.

How much debt does Microchip Technology have?

Microchip Technology's total liabilities were at $9.22 billion at the end of 2024, a 6.5% decrease from 2023, and a 238.8% increase since 2015.

How much cash does Microchip Technology have?

In the past 9 years, Microchip Technology's cash and equivalents has ranged from $234 million in 2023 to $2.09 billion in 2016, and is currently $319.70 million as of their latest financial filing in 2024.

How has Microchip Technology's book value per share changed over the last 9 years?

Over the last 9 years, Microchip Technology's book value per share changed from 10.15 in 2015 to 12.32 in 2024, a change of 21.4%.

Related Companies

This page (NASDAQ:MCHP) was last updated on 5/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microchip Technology (MCHP) Financials

Frequently Asked Questions About Microchip Technology's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Microchip Technology (MCHP) Financials

Annual Income Statements for Microchip Technology

Quarterly Income Statements for Microchip Technology

Annual Cash Flow Statements for Microchip Technology

Quarterly Cash Flow Statements for Microchip Technology

Annual Balance Sheets for Microchip Technology

Quarterly Balance Sheets for Microchip Technology

Annual Metrics And Ratios for Microchip Technology

Quarterly Metrics And Ratios for Microchip Technology

Frequently Asked Questions About Microchip Technology's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools